RxDoctor Payments Data

Michael Crim, DO

Family Medicine · Kansas City, MONPI 1982609699

Payments from drug & device makers

$5,117in general payments, 2019–2025

Across 318 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$814
  • AbbVie$573
  • Abbott$567
  • Amgen$431
  • Lilly USA, LLC$426
  • AstraZeneca$391
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$5,106100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,117 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$98,334
Medicare patients
356
Services billed
1,572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide94$178,856
JardianceEmpagliflozin110$147,351
EliquisApixaban101$118,041
MounjaroTirzepatide33$72,658
FarxigaDapagliflozin Propanediol48$43,180
XareltoRivaroxaban31$36,884
TrulicityDulaglutide16$35,970
Tresiba Flextouch U-200Insulin Degludec38$27,383
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$23,817
ShingrixVaricella-Zoster Ge/As01b/Pf91$20,070
InvokanaCanagliflozin12$19,705
JanuviaSitagliptin Phosphate20$17,506
MyrbetriqMirabegron16$13,430
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$12,929
LinzessLinaclotide18$12,452

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$814$178,85694 claims
Boehringer IngelheimJardiance, Stiolto Respimat$140$160,279123 claims
PfizerEliquis, Abrysvo$255$122,616117 claims
Lilly USA, LLCMounjaro, Trulicity$426$108,62849 claims
GSKTrelegy Ellipta, Shingrix, Arexvy, Anoro Ellipta$161$61,678176 claims
Johnson & JohnsonXarelto, Invokana$160$56,58943 claims
AstraZenecaFarxiga$391$43,18048 claims
MerckJanuvia$77$17,50620 claims
Astellas Pharma US IncMyrbetriq$33$13,43016 claims
AbbVieLinzess$573$12,45218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →